Dermal delivery of drugs using different vesicular carriers: A comparative review

Saahil Arora, Harleen Singh Lamba, Ravindra Tiwari

Abstract


Many skin diseases are based in the dermal layer of the skin like-acne, alopecia, psoriasis, herpes zoster, etc. Conventional topical formulations have not proved to be effective in managing these conditions because of poor retention in the
skin. Some formulations do not penetrate through the stratum corneum and some pass through the skin very quickly.Therefore, there is need to develop a strategy to deliver drugs to the dermis for better management of these conditions.
Vesicular systems like liposomes, niosomes, ethosomes and transfersomes have been used by many researchers to localize drugs in the dermal layer and have been fairly successful. Some vesicles were found to be more effective in retaining drug
to the skin and some were more effective in transdermal delivery. This article summarizes and compares the work done in the last decade on this topic and provides a conclusion.


Full Text:

PDF

References


Honeywell‐Nguyen PL, Bouwstra JA. The in vitro transport of pergolide

from surfactant‐based elastic vesicles thourough human skin:

A suggested mechanism of action. J Control Release 2003;86:145‐56.

Honeywell‐Nguyen PL, Frederik PM, Bomans PH, Junginger HE,

Bouwstra JA. Transdermal delivery of pergolide from surfactant‐based

elastic and rigid vesicles: Characterization and in vitro transport studies.

Pharm Res 2002;19:991‐7.

Honeywell‐Nguyen PL, Wouter Groenink HW, de Graaff AM,

Bouwstra JA. The in vivo transport of elastic vesicles into human skin:

Effects of occlusion, volume and duration of application. J Control

Release 2003;90:243‐55.

El Maghouraby GM, Barry BW, Williams AC. Liposomes and skin: From

drug delivery to model membranes. Eur J Pharm Sci 2008;34:203‐22.

Foldvari M, Gesztes A, Mezei M. Dermal drug deliver y by

liposome encapsulation: Clinical and electron microscopic studies.

J Microencapsul 1990;7:479‐89.

Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. Lipid vesicles

for skin delivery of drugs: Reviewing thouree decades of research. Int

J Pharm 2007;332:1‐16.

Sinico C, Fadda AM. Vesicular carriers for dermal drug delivery. Expert

Opin Drug Deliv 2009;6:813‐25.

Tortora GJ, Derrickson BH. Principles of Anatomy and Physiology. 12

ed. USA: John Wiley and Sons. 2008. p. 1280.

Bangham AD. Surrogate cells or trojan horses. The discovery of

liposomes. Bio Essays 1995;17:1081‐8.

Mezei M, Gulasekharam V. Liposomes-a selective drug delivery system

for the topical route of administration. Lotion dosage form. Life Sci

;26:1473‐7.

Mezei M, Gulasekharam V. Liposomes-a selective drug delivery system

for the topical route of administration: Gel dosage form. J Pharm

Pharmacol 1982;34:473‐4.

Planas ME, Gonzalez P, Rodriguez L, Sanchez S, Cevc G. Noninvasive

percutaneous induction of topical analgesia by a new type of drug

carrier, and prolongation of local pain insensitivity by anesthetic

liposomes. Anesth Analg 1992;75:615‐21.

Fisher R, Murphy M, Hung O, Mezei M, Stewart R. Absorption of

liposome‐encapsulated tetracaine versus nonliposome‐encapsulated

tetracaine from open wounds in rabbits. Am J Emerg Med 1994;12:521‐3.

Foldvari M. In vitro cutaneous and percutaneous delivery and in vivo

efficacy of tetracaine from liposomal and conventional vehicles. Pharm

Res 1994;11:1593‐8.

Foldvari M. Effect of vehicle on topical liposomal drug delivery:

Petrolatum bases. J Microencapsul 1996;13:589‐600.

Foldvari M. Non‐invasive administration of drugs thourough the

skin: Challenges in delivery system design. Pharm Sci Technol Today

;3:417‐25.

Singh R, Vyas SP. Topical liposomal system for localized and controlled

drug delivery. J Dermatol Sci 1996;13:107‐11.

Manconi M, Caddeo C, Sinico C, Valenti D, Mostallino MC, Biggio G,

et al. Ex vivo skin delivery of diclofenac by transcutol containing

liposomes and suggested mechanism of vesicle‐skin interaction. Eur J

Pharm Biopharm 2011;78:27‐35.

Mura S, Manconi M, Valenti D, Sinico C, Vila AO, Fadda AM. Transcutol

containing vesicles for topical delivery of minoxidil. J Drug Target

;19:189‐96.

Fresta M, Puglisi G. Application of liposomes as potential cutaneous

drug delivery systems. In vitro and in vivo investigation with

radioactively labelled vesicles. J Drug Target 1996;4:95‐101.

Handjani‐Vila RM, Ribier A, Rondot B, Vanlerberghie G. Dispersions of

lamellar phases of non‐ionic lipids in cosmetic products. Int J Cosmet

Sci 1979;1:303‐14.

Baillie AJ, Florence AT, Hume LR, Muirhead GT, Rogerson A. The

preparation and properties of niosomes-non‐ionic surfactant vesicles.

J Pharm Pharmacol 1985;37:863‐8.

Manconi M, Sinico C, Valenti D, Loy G, Fadda AM. Niosomes as

carriers for tretinoin. I. Preparation and properties. Int J Pharm

;234:237‐48.

Manconi M, Sinico C, Valenti D, Lai F, Fadda AM. Niosomes as carriers

for tretinoin. III. A study into the in vitro cutaneous delivery of

vesicle‐incorporated tretinoin. Int J Pharm 2006;311:11‐9.

Manconi M, Valenti D, Sinico C, Lai F, Loy G, Fadda AM. Niosomes as

carriers for tretinoin. II. Influence of vesicular incorporation on tretinoin

photostability. Int J Pharm 2003;260:261‐72.

Tabbakhian M, Tavakoli N, Jaafari MR, Daneshamouz S. Enhancement of

follicular delivery of finasteride by liposomes and niosomes 1. In vitro

permeation and in vivo deposition studies using hamster flank and ear

models. Int J Pharm 2006;323:1‐10.

Balakrishnan P, Shanmugam S, Lee WS, Lee WM, Kim JO, Oh DH,

et al. Formulation and in vitro assessment of minoxidil niosomes for

enhanced skin delivery. Int J Pharm 2009;377:1‐8.

van Hal DA, Jeremiasse E, Vringer T, Junginger HE, Bouwstra JA.

Encapsulation of lidocaine base and hydrochloride into non‐ionic

surfactant vesicles (NSVs) and diffusion thourough human stratum

corneum in vitro. Eur J Pharm Sci 1996;4:147‐57.

Carafa M, Santucci E, Lucania G. Lidocaine‐loaded non‐ionic surfactant

vesicles: Characterization and in vitro permeation studies. Int J Pharm

;231:21‐32.

Cevc G, Blume G. New, highly efficient formulation of diclofenac for the

topical, transdermal administration in ultradeformable drug carriers,

transfersomes. Biochim Biophys Acta 2001;1514:191‐205.

Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the

transdermal osmotic gradients and hydration force. Biochim Biophys

Acta 1992;1104:226‐32.

Cevc G. Drug delivery across the skin. Expert Opin Investig Drugs

;6:1887‐937.

Cevc G. Self‐regulating “smart carriers” for non‐invasive and targeted

drug delivery. Cell Mol Biol Lett 2002;7:224‐5.

Cevc G, Gebauer D, Stieber J, Schätzlein A, Blume G. Ultraflexible

vesicles, transfersomes, have an extremely low pore penetration

resistance and transport therapeutic amounts of insulin across the

intact mammalian skin. Biochim Biophys Acta 1998;1368:201‐15.

Cevc G, Mazgareanu S, Rother M. Preclinical characterisation of NSAIDs

in ultradeformable carriers or conventional topical gels. Int J Pharm

;360:29‐39.

Cevc G, Mazgareanu S, Rother M, Vierl U. Occlusion effect on

transcutaneous NSAID delivery from conventional and carrier‐based

formulations. Int J Pharm 2008;359:190‐7.

Cevc G, Gebauer D. Hydration‐driven transport of deformablelipid vesicles thourough fine pores and the skin barrier. Biophys J

;84:1010‐24.

Cevc G. Transdermal drug delivery of insulin with ultradeformable

carriers. Clin Pharmacokinet 2003;42:461‐74.

Cevc G, Blume G. Biological activity and characteristics of

triamcinolone‐acetonide formulated with the self‐regulating drug

carriers, transfersomes. Biochim Biophys Acta 2003;1614:156‐64.

Cevc G, Blume G. Hydrocortisone and dexamethasone in very

deformable drug carriers have increased biological potency, prolonged

effect, and reduced therapeutic dosage. Biochim Biophys Acta

;1663:61‐73.

Guo J, Ping Q, Sun G, Jiao C. Lecithin vesicular carriers for transdermal

delivery of cyclosporin A. Int J Pharm 2000;194:201‐7.

Trotta M, Peira E, Carlotti ME, Gallarate M. Deformable liposomes for

dermal administration of methotrexate. Int J Pharm 2004;270:119‐25.

Trotta M, Peira E, Debernardi F, Gallarate M. Elastic liposomes for skin

delivery of dipotassium glycyrrhizinate. Int J Pharm 2002;241:319‐27.

Jain S, Sapre R, Tiwary AK, Jain NK. Proultraflexible lipid vesicles

for effective transdermal delivery of levonorgestrel: Development,

characterization, and performance evaluation. AAPS Pharm Sci Tech

;6:E513‐22.

Jain SK, Gupta Y, Jain A, Rai K. Enhanced transdermal delivery of acyclovir sodium via elastic liposomes. Drug Deliv 2008;15:141‐7.

Badran M, Shalaby K, Al‐Omrani A. Influence of the flexible liposomes

on the skin deposition of a hydrophilic model drug, carboxyfluorescein:

Dependency on their composition. Sci World J 2012;2012:134876.

Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes ‐ novel

vesicular carriers for enhanced delivery: Characterization and skin

penetration properties. J Control Release 2000;65:403‐18.

Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A, Levi‐Schaffer F.

Intracellular delivery mediated by an ethosomal carrier. Biomaterials

;22:3053‐9.

Touitou E. Drug delivery across the skin. Expert Opin Biol Ther

;2:723‐33.

Touitou E, Meidan vm, Horwitz E. Methods for quantitative

determination of drug localized in the skin. J Control Release

;56:7‐21.

Kirjavainen M, Mönkkönen J, Saukkosaari M, Valjakka‐Koskela R,

Kiesvaara J, Urtti A. Phospholipids affect stratum corneum lipid bilayer

fluidity and drug partitioning into the bilayers. J Control Release

;58:207‐14.

Kirjavainen M, Urtti A, Valjakka‐Koskela R, Kiesvaara J, Mönkkönen J.

Liposome‐skin interactions and their effects on the skin permeation

of drugs. Eur J Pharm Sci 1999;7:279‐86.

Kirjavainen M, Urtti A, Jääskeläinen I, Suhonen TM, Paronen P,

Valjakka‐Koskela R, et al. Interaction of liposomes with human skin

in vitro-the influence of lipid composition and structure. Biochim

Biophys Acta 1996;1304:179‐89.

Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl:

Ethosomes vs. liposomes. Biomaterials 2000;21:1879‐85.

Ainbinder D, Touitou E. Testosterone ethosomes for enhanced

transdermal delivery. Drug Deliv 2005;12:297‐303.

Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M.

Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro

percutaneous permeation thourough human skin and in vivo

anti‐inflammatory activity on human volunteers. J Control Release

;106:99‐110.

López‐Pinto JM, González‐Rodríguez ML, Rabasco AM. Effect of

cholesterol and ethanol on dermal delivery from DPPC liposomes. Int

J Pharm 2005;298:1‐12.

Dubey V, Mishra D, Dutta T, Nahar M, Saraf DK, Jain NK. Dermal and

transdermal delivery of an anti‐psoriatic agent via ethanolic liposomes.

J Control Release 2007;123:148‐54.

Sinico C, Manconi M, Peppi M, Lai F, Valenti D, Fadda AM. Liposomes

as carriers for dermal delivery of tretinoin: In vitro evaluation of

drug permeation and vesicle‐skin interaction. J Control Release

;103:123‐36.

Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. Deformable

liposomes and ethosomes: Mechanism of enhanced skin delivery. Int

J Pharm 2006;322:60‐6.

El Maghouraby GM, Campbell M, Finnin BC. Mechanisms of action

of novel skin penetration enhancers: Phospholipid versus skin lipid

liposomes. Int J Pharm 2005;305:90‐104.

Fang JY, Hong CT, Chiu WT, Wang YY. Effect of liposomes and niosomes

on skin permeation of enoxacin. Int J Pharm 2001;219:61‐72.




DOI: http://dx.doi.org/10.22377/ajp.v6i4.40

Refbacks

  • There are currently no refbacks.